Bharat Biotech

red-blood-cells-3188223_1920

France, Germany Pause AstraZeneca Rollouts Over Sporadic Blood Clot Reports

The Wire Staff 16/03/2021

Governments are acting out of an abundance of caution...

dcgi-press-conference-vaccines-approval-of-covid_90514d50-4d9b-11eb-a035-42b692556fa6

Covaxin Exits ‘Clinical Trial Mode’, Centre Says

Bharat Biotech will have to continue the phase-3 clinical...

Vaccination drive in Bengaluru

India Retains Short Dose Gap For Covishield Despite Data To The Contrary

The Wire Staff 10/03/2021

An advisory group on immunisation had met in February...

Second phase of COVID vaccine drive in Patna

Covaxin Shows High Immune Response, Further Study Needed For Elderly

Anuron Kumar Mitra 10/03/2021

Study population lacked ethnic and gender diversity, with female...

What You Need To Know About the Covaxin Interim Efficacy Data

Dr Jammi Nagaraj Rao 04/03/2021

News of the reported efficacy is tempered by the...

Healthcare worker in a Mumbai slum for a COVID-19 check-up camp. Photo: Reuters/Francis Mascarenhas

COVID-19 Recovered People Showing Faster Antibody Response To Covishield

Single dose of Covishield is enough for individuals already...

FILE PHOTO: COVID-19 vaccination in New Delhi

Interim Results Show Covaxin Is 81% Effective, Bharat Biotech Says

The Wire Staff 03/03/2021

The Hyderabad-based company claimed that the vaccine candidate is...